Items where Author is "Aschner, M."

Article

(2025) Can infliximab serve as a new therapy for neuropsychiatric symptoms? Naunyn-Schmiedeberg's archives of pharmacology. pp. 1081-1097. ISSN 1432-1912 (Electronic) 0028-1298 (Linking)

(2025) Potential role of thymoquinone to treat gastrointestinal cancers: insights into its molecular mechanisms. Naunyn-Schmiedebergs Archives of Pharmacology. p. 27. ISSN 0028-1298

(2024) Effect of Aloe Vera against Natural and Chemical Toxicities. Current Nutrition and Food Science. ISSN 15734013 (ISSN)

(2024) Non-Coding RNAs and Neurodegenerative Diseases: Information of their Roles in Apoptosis. Molecular Neurobiology. pp. 4508-4537. ISSN 1559-1182 (Electronic) 0893-7648 (Linking)

(2024) Non-coding RNAs and Aquaporin 4: Their Role in the Pathogenesis of Neurological Disorders. Neurochemical Research. pp. 583-596. ISSN 1573-6903 (Electronic) 0364-3190 (Linking)

(2024) Potential of Edaravone Dexborneol in the treatment of cerebral ischemia: focus on cell death-related signaling pathways. Molecular Biology Reports. p. 11. ISSN 0301-4851

(2024) The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer's and Parkinson's Diseases. Cellular and Molecular Neurobiology. p. 16. ISSN 0272-4340

(2024) Therapeutic Potential of Fingolimod on Psychological Symptoms and Cognitive Function in Neuropsychiatric and Neurological Disorders. Neurochemical Research. pp. 2668-2681. ISSN 0364-3190

(2024) The therapeutic effects of berberine for gastrointestinal cancers. Asia-Pacific journal of clinical oncology. pp. 152-167. ISSN 1743-7563 (Electronic) 1743-7555 (Linking)

(2023) Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. Frontiers in Oncology. p. 25. ISSN 2234-943X

(2023) How gallic acid regulates molecular signaling: role in cancer drug resistance. Medical Oncology. p. 18. ISSN 1357-0560

(2023) Non-Coding RNAs and Neurodegenerative Diseases: Information of their Roles in Apoptosis. Molecular Neurobiology. p. 30. ISSN 0893-7648

(2022) Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target. NEUROCHEMICAL RESEARCH. pp. 860-871. ISSN 0364-3190 1573-6903 J9 - NEUROCHEM RES

(2022) Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target. Neurochemical research. pp. 860-871. ISSN 1573-6903 (Electronic) 0364-3190 (Linking)

(2022) Can Berberine Serve as a New Therapy for Parkinson's Disease? Neurotox Res. pp. 1096-1102. ISSN 1029-8428

(2022) Probiotics and the Treatment of Parkinson's Disease: An Update. Cellular and Molecular Neurobiology. pp. 2449-2457. ISSN 1573-6830 (Electronic) 0272-4340 (Print) 0272-4340 (Linking)

(2022) The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy. Molecular Biology Reports. pp. 10609-10615. ISSN 0301-4851

(2022) The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy. Mol Biol Rep. ISSN 0301-4851

(2021) Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers. FRONTIERS IN PHARMACOLOGY. ISSN 1663-9812 J9 - FRONT PHARMACOL

(2021) Aquaporin 4 and Brain-Related Disorders: Insights into Its Apoptosis Roles. Excli Journal. pp. 983-994. ISSN 1611-2156

(2021) Probiotics and the Treatment of Parkinson's Disease: An Update. Cell Mol Neurobiol. ISSN 0272-4340

(2021) Therapeutic potential of resveratrol in the treatment of glioma: Insights into its regulatory mechanisms. Mini Rev Med Chem. ISSN 1389-5575